CEACAM5 and cholangiocarcinoma: Several CCA-associated glycans such as carbohydrate antigen 19-9 (CA19-9), CA-S121, CA-S27 and carcinoembryonic antigen have been used as the glycobiomarkers or candidates for diagnosis, monitoring and prognostic prediction of CCA [4,5,6].